Exact Sciences Company Profile

00:29 EST 17th December 2018 | BioPortfolio

EXACT Sciences Corporation is an applied genomics company located in Maynard, MA. Founded in 1995, the company's mission is to play a leading role in the eradication of common cancers by applying advances in the field of genomics to facilitate early detection of disease. EXACT Sciences believes its proprietary, genomics-based technologies will revolutionize the early detection of colorectal and other common cancers. EXACT Sciences believes that widespread and periodic application of these non-invasive technologies will reduce the mortality, morbidity and healthcare costs associated with these diseases


100 Campus Drive
United States of America


Phone: 508-683-1200
Fax: 508-683-1201

News Articles [666 Associated News Articles listed on BioPortfolio]

EXACT Sciences' (EXAS) CEO Kevin Conroy on EXACT Sciences and Pfizer Cologuard Co-promotion Agreement - Call Transcript

Exact Sciences Shares Rise After Company Unveils Pfizer Partnership

[Updated 8/22/18 3:22 p.m. See below.] Exact Sciences has recently been ramping up its efforts to market Cologuard, the company’s flagship diagnostic test that screens patients for colorectal cancer...

Exact Sciences Seeks Up to $190M in Latest Stock Offering

Exact Sciences said Friday that it plans to raise up to $190 million through the sale of notes that can be converted into cash or shares of the company’s stock, starting in 2025. Madison, WI-based E...

Exact Sciences acquires Biomatrica

Exact Sciences has paid an undisclosed amount for San Diego-based Biomatrica, which makes blood and saliva collection tubes a -More- 

Exact Sciences Acquires San Diego Lab Equipment Supplier Biomatrica

Exact Sciences has gone from being a customer of Biomatrica, a San Diego-based vendor of equipment for storing and preserving blood and saliva samples, to now being the company’s owner. Madison, WI-...

Pfizer and Exact Sciences Enter Agreement to Co-Promote Colorectal Cancer Screening Test Cologuard

MADISON, Wis. and NEW YORK, Aug. 22, 2018 /PRNewswire/ — Exact Sciences Corp. (Nasdaq : EXAS ) and Pfizer Inc. (NYSE : PFE ) today announced an agreement through 2021 to co-promote Cologuard, th...

Rallye-Alarm bei Exact Sciences: 50 Prozent in zwei Tagen - Shortsqueeze!

Exact Sciences ist nach dem Vertriebsdeal mit dem Pharma-Konzern Pfizer nicht zu stoppen. Die Leeverkäufer, die sich nach den Quartalszahlen auf die Biotech-Gesellschaft eingeschossen hatten, müsse....

Exact Sciences Shares Rocket as Pfizer Agrees to Co-Market Cologuard Colon Cancer Test

Madison, Wisconsin-based EXACT Sciences stocks climbed as much as 21 percent in premarket trading in response to a deal with Pfizer to co-market Exact’s Cologuard non-invasive colon cancer test.

PubMed Articles [804 Associated PubMed Articles listed on BioPortfolio]

Cryptochrome 1 promotes osteogenic differentiation of human osteoblastic cells via Wnt/β-Catenin signaling.

The exact mechanism underlying osteoblast differentiation and proliferation remains to be further elucidated. The circadian clock has been universally acknowledged controls behavioral activities and b...

Exploiting Coordinate Scaling Relations to Accelerate Exact Exchange Calculations.

Exact exchange is an important constituent in many state of the art approximations to the exchange-correlation (xc) functional of Kohn-Sham DFT. However, its evaluation can be computationally intensiv...

iCFN: an efficient exact algorithm for multistate protein design.

Multistate protein design addresses real-world challenges, such as multi-specificity design and backbone flexibility, by considering both positive and negative protein states with an ensemble of subst...

Maximizing the clinical utility of descriptive lymphoid pathology reporting.

Dermatopathology reporting can be both exact and inexact. Exact reporting represents the use of terminology that corresponds to a disease sui generis, such as discoid lupus erythematosus or disseminat...

IL-17A Promotes Initiation and Development of Intestinal Fibrosis Through EMT.

Intestinal fibrosis is a common complication of Crohn's disease (CD). Its exact mechanism is still unclear, and effective treatments to control or reverse the fibrosis process are unavailable. Epithel...

Clinical Trials [517 Associated Clinical Trials listed on BioPortfolio]

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [1120 Associated Companies listed on BioPortfolio]

Exact Sciences

EXACT Sciences Corporation is an applied genomics company located in Maynard, MA. Founded in 1995, the company's mission is to play a leading role in the eradication of common cancers by applying adva...

Exact Macola

Exact is a leading global supplier of business software. Since we began in 1984, our focus has shifted from supporting financial processes to providing a complete ERP offering for...

Exact Sciences Corp.

Exact Sciences Corp. is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screen...

Exact Sciences Corporation

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The company has exclusive intellectual property p...

Connect Imaging

Connect Imaging Inc., founded in 1999, specializes in providing customized modular PACS, RIS (Radiology Information Systems), and Voice Recognition solutions to meet the exact wor...

More Information about "Exact Sciences" on BioPortfolio

We have published hundreds of Exact Sciences news stories on BioPortfolio along with dozens of Exact Sciences Clinical Trials and PubMed Articles about Exact Sciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Exact Sciences Companies in our database. You can also find out about relevant Exact Sciences Drugs and Medications on this site too.

Quick Search


Relevant Topic

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Corporate Database Quicklinks

Searches Linking to this Company Record